COMMUNIQUÉS West-GlobeNewswire

-
VIRBAC: exceptional first-half momentum (+16.2% at constant exchange rates) driven by all regions
16/07/2024 -
VIRBAC; dynamique exceptionnelle sur le premier semestre (+16,2% à taux de change constants) portée par toutes les régions
16/07/2024 -
RAMSAY SANTE :Refinancing of Senior Debt Facilities
16/07/2024 -
RAMSAY SANTE : Refinancement du contrat de dette senior
16/07/2024 -
ShiftWise Flex™ Launches Manager Hub App Enabling Mobile Workforce Management for Healthcare Organizations
16/07/2024 -
Innovation and Value Initiative Rebrands as the Center for Innovation & Value Research
16/07/2024 -
Dr. Reed Turpin Joins Center for Oral, Facial & Implant Surgery
16/07/2024 -
For the First Time in the Middle East In-Utero Endoscopic Surgery at KFSHRC Corrects Spinal Cord Defect in 26-Week-Old Fetus
16/07/2024 -
Nymox Required to Resubmit Application to DKMA
16/07/2024 -
SELLAS Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to SLS009 for the Treatment of Pediatric Acute Myeloid Leukemia
16/07/2024 -
Clearmind Medicine Obtains IND Approval from the FDA to Start the Phase I/IIa Clinical Trial with its Innovative Treatment for Alcoholism
16/07/2024 -
Anosh Inc. Foundation Reflects on a Year of Transformative Impact in 2023
16/07/2024 -
Alkeus Pharmaceuticals Appoints Tamara Dillon as Chief Human Resources Officer
16/07/2024 -
FLAG Therapeutics Announces Encouraging Preclinical Data from Studies of FLAG-003 for the Treatment of Diffuse Intrinsic Pontine Glioma (DIPG)
16/07/2024 -
RosenCare and PeopleOne Health Join Forces to Transform Healthcare Market in Florida
16/07/2024 -
The International Myeloma Foundation Mourns the Passing of IMF Board Member and Support Group Leader Jack Aiello
16/07/2024 -
Trethera Receives $2M NIH Grant for Preclinical Development in the Pediatric Neurologic Disease Acute Disseminated Encephalomyelitis
16/07/2024 -
Senti Bio Announces Reverse Stock Split
16/07/2024 -
CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical’s Selective Cytopheretic Device Pivotal Trial
16/07/2024
Pages